Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | DUT | P33316 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.33 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.33 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.33 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27883978 | 0.80 | CRBN (0.45) | CRBNALDH1A1LMNADDB1CA1 | |
| SCHEMBL3472507 | 0.77 | CRBN (0.47) | CRBNALDH1A1LMNADDB1CA1 | |
| SCHEMBL27509564 | 0.76 | CRBN (0.46) | CRBNALDH1A1LMNADDB1CA1 | |
| SCHEMBL27495405 | 0.76 | CRBN (0.46) | CRBNALDH1A1LMNADDB1CA1 | |
| SCHEMBL28816398 | 0.75 | CRBN (0.44) | CRBNALDH1A1LMNADDB1CA1 | |
| SCHEMBL2119230 | 0.75 | ALDH1A1 (0.44) | CRBNALDH1A1LMNADDB1CA1 | |
| SCHEMBL26034675 | 0.74 | ALDH1A1 (0.44) | ALDH1A1LMNADUTL3MBTL1PKM | |
| SCHEMBL28236112 | 0.73 | CRBN (0.43) | CRBNALDH1A1LMNADDB1CA1 | |
| SCHEMBL27952083 | 0.73 | L3MBTL1 (0.41) | CRBNALDH1A1LMNADDB1CA1 | |
| SCHEMBL11228302 | 0.73 | L3MBTL1 (0.50) | CRBNALDH1A1LMNADUTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3640305-B1 | USE OF A POLYMER WITH UCST IN A COATING COMPOSITION, IN PARTICULAR FOR PAINT, TO IMPROVE DRYING | CROMOLOGY (FR) | 2024-12-04 | — | — | EP | claimed |
| CN-116896712-A | Low-frequency displacement acoustic material, manufacturing method thereof, loudspeaker and electronic equipment | 镇江贝斯特新材料股份有限公司 | 2023-10-17 | — | — | CN | claimed |
| CN-115449038-A | Block copolymer, thermal response light modulation device and preparation method and application thereof | 华南师范大学 | 2022-12-09 | — | — | CN | claimed |
| CN-115135307-A | Carrier for cell delivery | 株式会社ITO | 2022-09-30 | — | — | CN | claimed |
| EP-3792271-A1 | A PROCESS FOR THE PREPARATION OF BRIVUDINE | Aurobindo Pharma Limited (IN) | 2021-03-17 | — | — | EP | claimed |
| CN-120058549-A | Polymers having an upper critical dissolution temperature in aqueous solution | 波音公司 | 2025-05-30 | — | — | CN | disclosed |
| EP-4506373-A2 | POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE IN AQUEOUS SOLUTION | The Boeing Company (US) | 2025-02-12 | — | — | EP | disclosed |
| CN-119242221-A | Lithium ion battery negative electrode bionic binder, preparation method thereof, lithium ion battery negative electrode slurry and negative electrode | 西部金属材料股份有限公司 | 2025-01-03 | — | — | CN | disclosed |
| EP-3969489-B1 | POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE IN AQUEOUS SOLUTION | BOEING CO (US) | 2024-12-25 | — | — | EP | disclosed |
| CN-115135307-B | Cell delivery vehicle | 株式会社ITO | 2024-11-22 | — | — | CN | disclosed |
| CN-113825776-B | Polymers having an upper critical dissolution temperature in aqueous solution | 波音公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-116896712-A | Low-frequency displacement acoustic material, manufacturing method thereof, loudspeaker and electronic equipment | 镇江贝斯特新材料股份有限公司 | 2023-10-17 | — | — | CN | disclosed |
| US-20230286911-A1 | POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE | THE BOEING COMPANY | 2023-09-14 | — | — | US | disclosed |
| US-11673858-B2 | Polymer with upper critical solution temperature | THE BOEING COMPANY (US) | 2023-06-13 | — | — | US | disclosed |
| CN-115449038-A | Block copolymer, thermal response light modulation device and preparation method and application thereof | 华南师范大学 | 2022-12-09 | — | — | CN | disclosed |
| CN-115135307-A | Carrier for cell delivery | 株式会社ITO | 2022-09-30 | — | — | CN | disclosed |
| EP-3969489-A1 | POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE IN AQUEOUS SOLUTION | The Boeing Company (US) | 2022-03-23 | — | — | EP | disclosed |
| CN-113825776-A | Polymers having an upper critical solution temperature in aqueous solution | 波音公司 | 2021-12-21 | — | — | CN | disclosed |
| EP-3792271-A1 | A PROCESS FOR THE PREPARATION OF BRIVUDINE | Aurobindo Pharma Limited (IN) | 2021-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11673858-B2 | Polymer with upper critical solution temperature | MPST, ULK2, ULK3 | CRBN 838/4885ALDH1A1 631/4885LMNA 2381/4885 |
| US-20230286911-A1 | POLYMER WITH UPPER CRITICAL SOLUTION TEMPERATURE | MPST, ULK2, ULK3 | CRBN 838/4885ALDH1A1 631/4885LMNA 2381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.